Your browser doesn't support javascript.
loading
Overcoming barriers in biomarker testing. Letter to the Editor regarding: 'ESMO study on the availability and accessibility of biomolecular technologies in oncology in Europe', by A. Bayle et al.
García-Foncillas, J; Arnold, D; Avouac, B; Lassen, U; Laurent-Puig, P; Taieb, J; Helland, Å; Stenzinger, A.
Affiliation
  • García-Foncillas J; University Cancer Institute & The Department of Oncology, University Hospital Fundacion Jimenez Diaz, Autonomous University, Madrid, Spain. Electronic address: jgfoncillas@gmail.com.
  • Arnold D; Asklepios Tumorzentrum Hamburg, AK Altona, Hamburg, Germany.
  • Avouac B; C2A, Paris, France.
  • Lassen U; Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  • Laurent-Puig P; Institut du Cancer Paris CARPEM, APHP, Université Paris Cité, Paris, France.
  • Taieb J; Georges Pompidou European Hospital SIRIC-CARPEM, Université Paris Cité, Paris, France.
  • Helland Å; Division of Cancer Medicine, Oslo University Hospital, University of Oslo, Oslo, Norway.
  • Stenzinger A; Institute of Pathology and Center for Personalized Medicine (ZPM), University Hospital Heidelberg, Heidelberg, Germany.
Ann Oncol ; 35(7): 677-678, 2024 Jul.
Article in En | MEDLINE | ID: mdl-38723866
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Neoplasms Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Biomarkers, Tumor / Neoplasms Limits: Humans Country/Region as subject: Europa Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2024 Document type: Article